Turnover: 235 million EUR (2022)

Country: France

  • Producer of dietary supplements
  • 900 employees
  • 5 international subsidiaries

News

Vitavea, Havea's factory of 1,000 natural health products in Vendée, France 11/08/2023

  • The Havea site covers 25 hectares near Montaigu, in the Vendée region
  • The company employs 900 people, half of whom are based in Montaigu.
  • Havea produces 1,200 products a year, 1,000 of which are manufactured in its Vendée plant
  • The group estimates the natural health market in Europe at around 15 billion euros, including 2 billion in France.
  • Havea achieved sales of 232 million euros in 2022 and forecasts total sales of 290 million euros in 2023.
  • The Vitavea and Biolane brands account for over 30% and 22% respectively of Havea's sales.
  • 60% of Havea sales are centered in France, and 90% in Europe.
  • The Group is also present in markets outside Europe, such as China and Canada.

Havea consolidates its manufacturing base in Vendée 05/07/2023

  • The French Havea Group has taken over the German company Bears with Benefits.
  • Havea plans to invest 5 million euros in a chewing gum line.
  • The gum line will have a capacity of 4 million boxes a year.
  • The Vendée-based company recently completed its seventh acquisition in six years.
  • The Montaigu plant is home to half of the group's 450-strong workforce.
  • A project to increase capsule production from 400 million to 600 or 700 million is scheduled for the second half of 2024.
  • Havea, taken over in October 2022 by the BC Partners fund, will achieve sales of 290 million euros this year.
  • The group has gained 104 million euros in sales through acquisitions since 2017.
  • Havea aims to gain a further 200 million euros in sales through acquisitions by 2027.

Havea Group: Natural health specialist 30/06/2023

  • Sales target for Havea Group in 2021 is around 300 million euros, an increase of 20%.
  • The sales target for Havea Group in 2027 is one billion euros.
  • 60% of Havea Group sales are generated in France.
  • The growing "natural health" market in Europe is worth around 15 billion euros.
  • Havea Group's product portfolio comprises some 1,200 products.
  • Havea Group was acquired by the British investment fund BC Partners for 1.16 billion euros.
  • 950 employees, including 450 at its Montaigu plant and 250 in Paris.

Havea acquires Biocyte nutricosmetics. 01/02/2023

  • Havea sales of €235 million by 2022
  • 900 employees, including 400 at its Vendée plant
  • Biocyte brings its purchaser 50 employees and sales of €23 million
  • With a strong presence in some twenty countries, the company has a strong position in China, where it generates sales of €7 million
  • This is the group's seventh acquisition in six years, and its second since its takeover in October 2022

Vendée-based Havea launches a new series of acquisitions 09/11/2022

  • Acquisition of German company Bears with Benefits
  • The company is profitable and will achieve sales of 15 million euros in 2022 with 25 employees.
  • Italy accounts for 50% of sales
  • Vendée-based group specializing in hygiene products and dietary supplements
  • sixth acquisition in six years.
  • Germany, Europe's second-largest market for dietary supplements
  • 800 employees at this industrial site, which manufactures over 85% of its products.
  • New majority shareholder BC Partners values Havea at 1.1 billion euros

Havea dreams of becoming Europe's number one in natural health 09/11/2022

  • Bought out by BC Partners for over 1 billion euros
  • French champion in dietary supplements
  • Acquisition of German nugget Bears with Benefits
  • Objective: sales of 1 billion euros by 2027.
  • sixth acquisition in six years
  • 850 employees, half in Vendée
  • 60% of sales in France
  • 500 million euros to be invested in acquisitions
  • 15-billion euro market in Europe still highly fragmented
  • Largest players in Europe: Spain's Uriach, Italy's Aboca, Germany's Dermapharm

Financial Data

DUNS: 823334578

Legal Name: HAVEA GROUP

Address: parc d'activité sud loire, Boufféré , 85612 Montaigu CEDEX

Number of employees: Entre 20 et 49 salariés (2020)

Capital: 211 096 234 EUR


Financial Data:

Year 2020 2019 2018 2017
Turnover 4 487 105 3 510 289 619 500 273 051
Gross margin (€) 8 881 352 6 281 112 2 951 334 2 564 985
EBITDA (€) -400 186 -2 293 207 -2 842 917 -2 159 120
Operating profit (€) -1 634 439 -3 530 867 -3 833 841 -2 762 206
Net profit (€) -14 362 044 -12 679 287 -10 564 058 -8 712 352
Turnover growth rate (%) 27,8 466,6 126,9 1 763,7
Ebitda margin rate (%) -8,9 -65,3 -458,9 -790,7
Operating margin rate (%) -36,4 -100,6 -618,9 -1 011,6
Working Capital (turnover days) 2 701,8 3 493,5 12 788,4 -1 041,1
Working Capital requirements (turnover days) 181,9 260,7 -909,1 -2 744
Net margin (%) -320,1 -361,2 -1 705,3 -3 190,7
Added value / Turnover (%) -18,6 -24,1 -340,4 -740,2
Wages and social charges (€) 2 982 342 2 333 792 678 123 134 602
Salaries / Turnover (%) 66,5 66,5 109,5 49,3

Company Managers:

Position First Name Last Name Age Linkedin
Directeur général Matthieu, Paul, Charles MOURETTE 44

Studies mentioning this company

The complementary health products market - France

Other companies mentioned:

The food supplements market - France

Other companies mentioned:

The dermocosmetics market - France

Other companies mentioned: